TI
ACET icon

Trexquant Investment’s Adicet Bio ACET Stock Holding History

Trexquant Investment’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
+43,666
New +$327K ﹤0.01% 1598
2023
Q3 		– Sell
-6,330
Closed -$246K – 1414
2023
Q2 		$246K Buy
6,330
+5,640
+817% +$498K 0.01% 1252
2023
Q1 		$63.6K Buy
+690
New +$86.6K ﹤0.01% 1391
2022
Q3 		– Sell
-685
Closed -$160K – 1310
2022
Q2 		$160K Buy
+685
New +$150K 0.01% 1400

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Trexquant Investment's ACET Position: Q1 2026 in Review

Trexquant Investment opened a new position in Adicet Bio (ACET) in Q1 2026: 43,666 shares worth $297K. The stake represents ﹤0.01% of the portfolio and ranks #1598 among its holdings. This is a return to the name: Trexquant Investment previously reported a position in ACET as recently as Q2 2023.

Trexquant Investment first reported a position in ACET in Q2 2022 and has held it in 4 quarters since. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Trexquant Investment held 43,666 shares of Adicet Bio worth $297K as of Q1 2026.
  • Adicet Bio was a new Trexquant Investment position in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1598 holding.
  • Trexquant Investment first reported a position in Adicet Bio in Q2 2022 and has held it in 4 quarters since.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.